Mark Tengler
Mark Tengler
NEOS Therapeutics Inc.
2940 N Hwy 360 # 100
Grand Prairie,
TX
USA
75050
Papers:
3.40
Oral Bioavailability/Bioequivalence of a Novel Investigational Extended-Release Oral Disintegrating Tablet Formulation of Amphetamine for ADHD
3.41
Pharmacokinetic Study of a Novel Extended-Release Formulation of Amphetamine Oral Disintegrating Tablet in Children Ages 6-12 with ADHD